Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,264 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Active, Not Recruiting

TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)

NCT05862324

Conditions
Metastatic Solid Tumor, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • University of Southern California Los Angeles, California, United States
  • University of California San Diego San Diego, California, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT05348577

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Research Site Yuma, Arizona, United States
  • Research Site Beverly Hills, California, United States
  • Research Site Cerritos, California, United States
  • Research Site Fresno, California, United States
View all 217 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

NCT04685135

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • Local Institution - 012-898 Cerritos, California, United States
  • City of Hope - Duarte (Main Campus) Duarte, California, United States
  • Local Institution - 012-898 D Glendale, California, United States
  • Local Institution - 012-910-A Huntington Beach, California, United States
View all 343 locations
View Trial Details
Active, Not Recruiting

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

NCT05688280

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +36 more
Locations
  • Miami Cardiac & Vascular Institute Coral Gables, Florida, United States
  • University of Louisville Physicians, PSC Louisville, Kentucky, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Institut Bergonie Bordeaux, France
View all 16 locations
View Trial Details
Active, Not Recruiting

Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC

NCT03616886

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +9 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • Cliniques universitaires Saint Luc Brussels, Belgium
  • Grand Hôpital de Charleroi Charleroi, Belgium
  • UZ Leuven Gasthuisberg Leuven, Belgium
View all 16 locations
View Trial Details
Active, Not Recruiting

RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors

NCT05052255

Conditions
Advanced Solid Tumor, Disease Attributes, Neoplasm Metastasis, +5 more
Locations
  • Beskidzkie Centrum Onkologii, Szpital Miejski im. Bielsko-Biala, Poland
  • Medical University Early Phase 1 Research Center / Uniwersyteckie Centrum Kliniczne Ośrodek Badań Klinicznych Wczesnych Faz Gdansk, Poland
  • UCK im. prof. K. Gibińskiego Katowice, Poland
  • Maria Sklodowska-Curie National Research Institute of Oncology / Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Warsaw, Poland
View Trial Details
Active, Not Recruiting

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details

Related conditions